ResMed (ASX:RMD) acquired VirtuOx, a US-based diagnostic testing provider for sleep, respiratory, and cardiac conditions, according to a Thursday statement by the company.
Under the deal, VirtuOx will operate as the company's unit and offer its at-home diagnostic services, per the statement.
Financial terms of the deal were not disclosed, with the company stating the acquisition is not material to its financial results.
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。